Former Shareholder

Benchmark International Successfully Facilitated the Transaction Between Quantum3 Aluminium Limited and Burke Porter Group

Benchmark International is pleased to announce the acquisition of Killaloe-headquartered Quantum 3 (Q3) by Michigan-based Burke Porter Group (BPG).

Established in 2000, Q3 manufactures a range of lean and flexible aluminium profile and framing systems, featuring patented connector blocks, for manufacturers in the medical and life sciences industries. Leveraging its unique modular flexible aluminium profile and framing systems, the company designs lean assembly and production line solutions that enable customers to optimise their workflows and realise process improvements in cleanroom and other demanding environments.

Over the last 20 years, Q3 has served clients in Ireland, the U.S. and Costa Rica.

Founded in 1953 and headquartered in Grand Rapids, Michigan, BPG is a leading global supplier of automated diagnostic, testing and production solutions serving life science and speciality industrial end markets. BPG focuses on automating high-precision processes, leveraging its capabilities in microfluidics, optical design, additive manufacturing, motion control and software to develop solutions tailored to its customers' needs.

BPG maintains close proximity to its worldwide customer base through a global footprint of 45 locations to provide responsive and local supply, service and support.

Following the acquisition, Q3 founders Pat Hayes and Paul McGrath will remain with the company, working closely with the BPG leadership team and Rich Carone, who leads BPG's Medical and Life Sciences Division.

Mr. Hayes said this about the acquisition: "Joining a proven and creative company like BPG is a great opportunity for Q3 to expand our global reach and develop our capabilities. Plus, BPG's 'innovation-first' mindset and relentless focus on the customer fit perfectly with our culture and mission, making this an exciting next step for Q3's growth."

CEO of BPG said: "The strength of Quantum 3's relationships with medical and life science OEM companies in conjunction with its collaborative engineering approach perfectly complements BPG's offering.

“We are excited at the opportunity of expanding our footprint into Ireland, one of the world's most important biomedical markets, while strengthening our portfolio of solutions across emerging and growing markets."

Mr. Carone added: "Pat and Paul have assembled a highly talented, motivated team with excellent customer relations. We are really looking forward to partnering with them to create a synergy that strengthens all of us, providing even more value for our customers.